 
Convergence of Type 2 Diabetes and Cardiovascular
Disease
In conjunction with
Northern New England Chapter of the American College of Cardiology
Annual Meeting 2009
Program Chair: Donna Polk, MD, FACC
Saturday, November 7, 2009
1:00 p.m. – 3:00 p.m.
Sheraton Harborside Hotel
Portsmouth, New Hampshire
 |
Learning Pathway: General Cardiology: Hypertension,
Lipids and Prevention
|
| The ACCF is pleased to present
a two-year educational initiative on The Convergence of
Diabetes and Cardiovascular Disease: Current Insights and
Future Directions which will incorporate comprehensive
needs assessment, program planning, evaluation and outcomes,
and educational interventions that broaden the emphasis from
knowledge dissemination to change in clinical practice, behavior
and outcomes. Click
here for further information on this
initiative.
|
PROGRAM
OVERVIEW
Statement of Need
Recent studies have identified the clear correlation between coronary
heart disease and type 2 diabetes mellitus. Diabetes increases the
risk of coronary artery disease (CAD) by a factor of 2- to 4-fold.
Myocardial ischemia is a major complication in the course of diabetes,
causing 75% of diabetes-related deaths. Patients with diabetes also
have a higher rate of sudden death and poorer outcomes after myocardial
infarction (MI). Compared with a non-diabetic individual, a person
with type 2 diabetes has a 2- to 4-fold risk of dying from MI or
a stroke and a 10- to 15-fold increased risk of lower extremity
amputation. In addition mortality among diabetic patients from a
coronary artery incident is rising. In fact more than 65% of people
with diabetes die from heart disease or stroke.
Despite ongoing dissemination of evidence-based guidelines for
health care professionals and patients, there remains an estimated
20 million people in the United States, 7% of the population, who
suffer from diabetes which is a significant cause of morbidity and
disability. To address this need, the American College of Cardiology
Foundation is conducting a two-year initiative to increase awareness
and education to medical professionals on the intersection of cardiovascular
disease and type 2 diabetes mellitus.
Overview
Join the American College of Cardiology during the Northern New
England Chapter of the American College of Cardiology Annual Meeting
2009 for a stimulating session on The Convergence of Type 2
Diabetes and Cardiovascular Disease. The expert faculty will
examine the clear correlation between coronary heart disease and
type 2 diabetes mellitus and developments in this dynamic field.
Participants will have an opportunity to participate in question
and answer sessions and discuss case presentations.
Learner Objectives
The overall goal of this session is to enhance participants’
competence by providing the most up-to-date information on the correlation
of type 2 diabetes and cardiovascular disease.
Upon completion of this program, attendees should be able to —
- Describe the prevalence of CV disease in patients with diabetes
- Identify patients with known diabetes and those at risk for
diabetes, who are at significantly increased risk for CV disease
based on the most current screening and treatment guidelines
- Apply modifiable and controllable risk factor strategies in
the daily management of patients with diabetes and/or CV disease,
to achieve evidence-based optimal outcomes
FACULTY
Program Chair
Donna Polk, MD, FACC
Director Preventive Cardiology
Henry Low Heart Center
Director Women’s Heart Program
Hartford Hospital
Hartford, CT
Invited Faculty
Howard Weintraub, MD, FACC
Clinical Associate Professor
Department of Medicine (Cardiology)
New York University Medical Center
New York, NY
DISCLOSURES
ACCF faculty, committee members, staff and other
individuals who are in a position to control the content of this
activity are required to disclose all real or apparent conflicts
of interest. All relevant potential conflicts of interest that are
identified are thoroughly vetted through a process that includes
course directors and appropriate peer review by education committee
chairs/members, for fair balance, scientific objectivity and validity,
patient care and safety recommendations. Refer to the links below
for committee member disclosures and program faculty disclosures.
Please note ACCF staff involved with this program have nothing to
disclose.
ACC
Live Programs Committee (2007-2010) disclosures
Convergence
of Type 2 Diabetes and Cardiovascular Disease Faculty disclosures
LEARNER BILL
OF RIGHTS
Learner
Bill of Rights
AGENDA
The Northern New England Chapter of the American College of Cardiology
Annual Meeting 2009 will be held November 7, 2009. The ACCF Convergence
of Type 2 Diabetes and Cardiovascular Disease session will be held
from 1:00 p.m. to 3:00 p.m. For complete program information click
here.
TARGET
AUDIENCE
This program is intended for physicians, physician
assistants, Fellows in Training, nurses, nurse practioners and others
interested in the relationship between type 2 diabetes and cardiovascular
disease.
ACCREDITATION
The American College of Cardiology Foundation is accredited by the
Accreditation Council for Continuing Medical Education to provide
continuing medical education for physicians.
The ACCF designates The Convergence of Type 2 Diabetes and Cardiovascular
Disease portion of this educational activity for a maximum of 2
AMA PRA Category 1 Credits™. Physicians should only
claim credits commensurate with the extent of their participation
in the activity.
While offering CME credits noted above, the program is not intended
to provide extensive training or certification in the field .
REGISTRATION
To register for the the Northern New England Chapter of the American
College of Cardiology Annual Meeting 2009 click
here.
ACCOMMODATIONS
Location
The program will be held at the Sheraton
Harborside Hotel, 250 Market Street,Portsmouth NH 03801. The
meeting site telephone number is (603)431.2300.
GENERAL
INFORMATION
Tuition
The registration tuition includes admission to The Convergence of
Type 2 Diabetes and Cardiovascular Disease program.
Please Note
Smoking is prohibited in all ACCF meeting rooms.
Videotaping, audiotaping and still photography are prohibited in
all ACCF meeting rooms.
We encourage participation by all individuals. If you have a disability,
advance notification of any special needs will help us serve you
better.
Faculty and program are subject to change without notice.
Accredited status does not imply endorsement by the ACCF of any
commercial products displayed in conjunction with this activity.
The views expressed in this program are those of the individual
speaker and do not necessarily reflect the views of ACCF.
ACKNOWLEDGMENTS
Major support for this activity is provided through
an educational grant from:
Additional support is provided through an educational grant from:
|
